AU2002344519A1 - Activity of osteogenic growth peptide (ogp) for promoting proliferation of hemopoietic progenitor cell in erythron and its use - Google Patents
Activity of osteogenic growth peptide (ogp) for promoting proliferation of hemopoietic progenitor cell in erythron and its useInfo
- Publication number
- AU2002344519A1 AU2002344519A1 AU2002344519A AU2002344519A AU2002344519A1 AU 2002344519 A1 AU2002344519 A1 AU 2002344519A1 AU 2002344519 A AU2002344519 A AU 2002344519A AU 2002344519 A AU2002344519 A AU 2002344519A AU 2002344519 A1 AU2002344519 A1 AU 2002344519A1
- Authority
- AU
- Australia
- Prior art keywords
- erythron
- ogp
- activity
- progenitor cell
- promoting proliferation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2002/000737 WO2004035081A1 (en) | 2002-10-21 | 2002-10-21 | Activity of osteogenic growth peptide (ogp) for promoting proliferation of hemopoietic progenitor cell in erythron and its use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002344519A1 true AU2002344519A1 (en) | 2004-05-04 |
Family
ID=32097414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002344519A Abandoned AU2002344519A1 (en) | 2002-10-21 | 2002-10-21 | Activity of osteogenic growth peptide (ogp) for promoting proliferation of hemopoietic progenitor cell in erythron and its use |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN100506275C (en) |
AU (1) | AU2002344519A1 (en) |
WO (1) | WO2004035081A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2835124T3 (en) * | 2016-03-23 | 2021-06-21 | Kine Sciences Co Ltd | Peptide for skin regeneration or wound treatment and its use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5461034A (en) * | 1989-02-23 | 1995-10-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Osteogenic growth polypeptides identified from regenerating bone marrow |
-
2002
- 2002-10-21 AU AU2002344519A patent/AU2002344519A1/en not_active Abandoned
- 2002-10-21 CN CNB028297741A patent/CN100506275C/en not_active Expired - Fee Related
- 2002-10-21 WO PCT/CN2002/000737 patent/WO2004035081A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN100506275C (en) | 2009-07-01 |
WO2004035081A1 (en) | 2004-04-29 |
CN1688332A (en) | 2005-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003259055A1 (en) | Cell and tissue culture device | |
AU2003217350A1 (en) | Proliferated cell lines and uses thereof | |
AU2003254211A1 (en) | Bone repair putty comprising porous particulate and carrier gel | |
AU2003216144A1 (en) | Long-acting hormone and growth factor compositions and uses thereof | |
HK1069323A1 (en) | Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof | |
AU2003221173A1 (en) | Placenta-origin mesenchymal cells and medicinal use thereof | |
AU2003276937A1 (en) | Vegetable protein preparations and use thereof | |
AU2003274900A1 (en) | Cellular reprogramming in peptide hydrogel and uses thereof | |
AU2002952181A0 (en) | Electrolysis process and cell for use in same | |
AU2003298520A1 (en) | Vapor deposited catalysts and their use in fuel cells | |
AU2002344519A1 (en) | Activity of osteogenic growth peptide (ogp) for promoting proliferation of hemopoietic progenitor cell in erythron and its use | |
AU2003228431A1 (en) | Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells | |
AU3170499A (en) | Fibroblast growth factor mutein compositions and methods of use therefor | |
AU2003207503A1 (en) | Methods and compositions for oxygen transport comprising modified hemoglobin in plasma | |
AU2003241103A1 (en) | Compositions containing anti-hiv peptides and methods of use | |
AUPS238502A0 (en) | Cystic echinococcosis protein and uses therefor | |
AU2002309989A1 (en) | Directed evolution of protein in mammalian cells | |
AU2003207628A1 (en) | Structural and cytoskeleton-associated proteins | |
HUP0203504A3 (en) | Modified peptides and peptidomimetics for use in immunotherapy | |
AU2003244241A1 (en) | Promoter for uptake of basic amino acid into cell and cosmetic or drug composition | |
AU2003275123A1 (en) | Composition containing ribavirin and use thereof | |
MY143821A (en) | Biologically active peptide comprising tyrosyl-seryl-valine (ysv) | |
AU2003246257A1 (en) | Cell culture carrier and cell culture unit | |
AU2003213933A1 (en) | Purified polypeptides involved in protein synthesis and modification | |
AU3703200A (en) | Recombinant protein c activator and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |